The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...

CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

The following is a summary of “Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With ...

VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...

A recent case report describes a 63-year-old woman in China who was diagnosed with a rare variant of the RhD antigen.

Vanderbilt University Medical Center has been awarded up to $30 million by the Advanced Research Projects Agency for Health ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...

Peptic ulcer disease is a common digestive disorder in which acid and digestive enzymes cause the lining of the stomach or the first part of the small intestine (duodenum) to erode. A peptic ulcer ...

Clinical outcomes from a prospective study of comprehensive genomic testing in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the ...